本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ProQR Therapeutics N.V.

2.26
-0.1400-5.83%
盘后2.260.00000.00%19:06 EDT
成交量:28.05万
成交额:65.46万
市值:2.38亿
市盈率:-6.22
高:2.47
开:2.42
低:2.25
收:2.40
数据加载中...
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]